Last reviewed · How we verify
Lavandula angustifolia, Aura Cacia — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Lavandula angustifolia, Aura Cacia (Lavandula angustifolia, Aura Cacia) — University of Florida.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lavandula angustifolia, Aura Cacia TARGET | Lavandula angustifolia, Aura Cacia | University of Florida | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lavandula angustifolia, Aura Cacia CI watch — RSS
- Lavandula angustifolia, Aura Cacia CI watch — Atom
- Lavandula angustifolia, Aura Cacia CI watch — JSON
- Lavandula angustifolia, Aura Cacia alone — RSS
Cite this brief
Drug Landscape (2026). Lavandula angustifolia, Aura Cacia — Competitive Intelligence Brief. https://druglandscape.com/ci/lavandula-angustifolia-aura-cacia. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab